Human CXCL1/FSP/GRO1 ORF/cDNA clone-Lentivirus plasmid (NM_001511)
Cat. No.: pGMLP000056
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CXCL1/FSP/GRO1 Lentiviral expression plasmid for CXCL1 lentivirus packaging, CXCL1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
CXCL1/FSP products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000056 |
| Gene Name | CXCL1 |
| Accession Number | NM_001511 |
| Gene ID | 2919 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 324 bp |
| Gene Alias | FSP,GRO1,GROa,MGSA,MGSA-a,NAP-3,SCYB1 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCCCGCGCTGCTCTCTCCGCCGCCCCCAGCAATCCCCGGCTCCTGCGAGTGGCACTGCTGCTCCTGCTCCTGGTAGCCGCTGGCCGGCGCGCAGCAGGAGCGTCCGTGGCCACTGAACTGCGCTGCCAGTGCTTGCAGACCCTGCAGGGAATTCACCCCAAGAACATCCAAAGTGTGAACGTGAAGTCCCCCGGACCCCACTGCGCCCAAACCGAAGTCATAGCCACACTCAAGAATGGGCGGAAAGCTTGCCTCAATCCTGCATCCCCCATAGTTAAGAAAATCATCGAAAAGATGCTGAACAGTGACAAATCCAACTGA |
| ORF Protein Sequence | MARAALSAAPSNPRLLRVALLLLLLVAAGRRAAGASVATELRCQCLQTLQGIHPKNIQSVNVKSPGPHCAQTEVIATLKNGRKACLNPASPIVKKIIEKMLNSDKSN |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T96005-Ab | Anti-GROA/ CXCL1/ FSP functional antibody |
| Target Antigen | GM-Tg-g-T96005-Ag | CXCL1 protein |
| Cytokine | cks-Tg-g-GM-T96005 | chemokine (C-X-C motif) ligand 1 (CXCL1) protein & antibody |
| ORF Viral Vector | pGMLP000056 | Human CXCL1 Lentivirus plasmid |
| ORF Viral Vector | pGMAD001667 | Human CXCL1 Adenovirus plasmid |
| ORF Viral Vector | vGMLP000056 | Human CXCL1 Lentivirus particle |
| ORF Viral Vector | vGMAD001667 | Human CXCL1 Adenovirus particle |
Target information
| Target ID | GM-T96005 |
| Target Name | CXCL1 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
2919 |
| Gene ID | 2919 (Homo sapiens), 574222 (Macaca mulatta) |
| Gene Symbols & Synonyms | CXCL1,FSP,GRO1,GROa,MGSA,NAP-3,SCYB1,MGSA-a |
| Target Alternative Names | C-X-C motif chemokine 1,CXCL1,FSP,GRO-alpha(1-73),GRO1,GROa,Growth-regulated alpha protein,MGSA,MGSA-a,Melanoma growth stimulatory activity (MGSA),NAP-3,Neutrophil-activating protein 3 (NAP-3),SCYB1 |
| Uniprot Accession |
P09341
Additional SwissProt Accessions: P09341 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, Immuno-oncology Target, Cytokine Target |
| Disease | cancer, Prostate Cancer, Malignant neoplasm of bladder |
| Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Chemokine signaling pathway, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, IL-17 signaling pathway, TNF signaling pathway, Alcoholic liver disease, Epithelial cell signaling in Helicobacter pylori infection, Legionellosis, Amoebiasis, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Lipid and atherosclerosis |
| Gene Ensembl | ENSG00000163739, ENSMMUG00000008367 |
| Target Classification | Checkpoint-Immuno Oncology |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


